Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cryo-Cell International | CCEL | Aug 30, 2024 | 6.20 | -4.47 |
CryoPort | CYRX | Aug 30, 2024 | 9.32 | +3.56 |
CS Disco | LAW | Aug 30, 2024 | 5.53 | -0.90 |
CSG Systems International | CSGS | Aug 30, 2024 | 48.52 | +1.49 |
CSP | CSPI | Aug 30, 2024 | 13.90 | +0.36 |
CSW Industrials | CSWI | Aug 30, 2024 | 337.63 | +2.74 |
CSX | CSX | Aug 30, 2024 | 34.27 | +0.97 |
CTO Realty Growth | CTO | Aug 30, 2024 | 19.02 | +0.53 |
CTO Realty Growth A Pref | CTO-A | Aug 30, 2024 | 23.10 | -0.56 |
CTS | CTS | Aug 30, 2024 | 49.25 | +0.59 |
CubeSmart | CUBE | Aug 30, 2024 | 51.83 | +0.64 |
Cue Biopharma | CUE | Aug 30, 2024 | 0.72 | +0.21 |
Cullen Frost Bankers B Pref | CFR-B | Aug 30, 2024 | 20.94 | -1.92 |
Cullen/Frost Bankers | CFR | Aug 30, 2024 | 112.23 | -0.17 |
Cullinan Therapeutics | CGEM | Aug 30, 2024 | 19.60 | +3.92 |
Cullman Bancorp | CULL | Aug 30, 2024 | 9.71 | 0.00 |
Culp | CULP | Aug 30, 2024 | 5.02 | +0.20 |
Cumberland Pharmaceuticals | CPIX | Aug 30, 2024 | 1.35 | -0.74 |
Cummins | CMI | Aug 30, 2024 | 312.85 | +1.14 |
Cumulus Media A | CMLS | Aug 30, 2024 | 1.66 | -1.78 |
Curevac N.V. | CVAC | Aug 30, 2024 | 3.14 | -2.48 |
CuriosityStream | CURI | Aug 30, 2024 | 1.54 | +6.21 |
Curis | CRIS | Aug 30, 2024 | 5.53 | +0.27 |
Curtiss-Wright | CW | Aug 30, 2024 | 315.86 | +0.46 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Aug 30, 2024 | 43.08 | -0.52 |
Cushman & Wakefield | CWK | Aug 30, 2024 | 13.00 | +1.01 |
Custom Truck One Source | CTOS | Aug 30, 2024 | 4.10 | -3.53 |
Customers Bancorp | CUBI | Aug 30, 2024 | 51.82 | +0.39 |
Customers Bancorp E Pref | CUBI-E | Aug 30, 2024 | 25.07 | -2.64 |
Customers Bancorp F Pref | CUBI-F | Aug 30, 2024 | 24.99 | -2.08 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.